Efficacy and safety of antiviral therapy for HBV in different trimesters of pregnancy: systematic review and network meta-analysis
ConclusionThis network meta-analysis recommended the earlier use of telbivudine or tenofovir, tends to be better to prevent MTCT of HBV in pregnancy with no increased adverse maternal or fetal outcomes.
Source: Hepatology International - Category: Infectious Diseases Source Type: research
More News: Antiviral Therapy | Children | Databases & Libraries | Infectious Diseases | Pregnancy | Science | Statistics | Study | Viread